SCHEMBL8960651

SCHEMBL8960651

c1ccc(-c2nc(-c3ccccc3)c(-c3ccc[nH]3)s2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 5/20 0.47
DBF4 Q9UBU7 5/20 0.47
PTGS2 P35354 1/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
COMT P21964 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PTGDR2 Q9Y5Y4 2/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
RARA P10276 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
ALOX5 P09917 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8960660 0.87 CYP1A2 (0.49) CDC7DBF4PTGS2ALDH1A1KDM4E
SCHEMBL9768642 0.79 ALDH1A1 (0.62) CDC7DBF4PTGS2ALDH1A1KDM4E
SCHEMBL7852125 0.72 ALDH1A1 (0.50) PTGS2ALDH1A1KDM4ENPC1LMNA
SCHEMBL11456658 0.71 CDC7 (0.67) CDC7DBF4PTGS2ALDH1A1KDM4E
SCHEMBL21670773 0.71 PTGS2 (0.56) CDC7DBF4PTGS2ALDH1A1KDM4E
SCHEMBL11287147 0.70 PTGS2 (0.74) PTGS2ALDH1A1KDM4EPTGDR2MAPT
SCHEMBL9958269 0.70 ALDH1A1 (0.51) CDC7DBF4PTGS2ALDH1A1KDM4E
SCHEMBL11284205 0.70 KDM4E (0.58) PTGS2ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL11460695 0.70 KDM4E (0.58) PTGS2ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL12245630 0.70 ALOX5 (0.69) PTGS2ALDH1A1KDM4ELMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0560136-B1 Neuroprotective drug KANEBO LTD (JP) 1996-01-24 EP disclosed
US-5399571-A Antihypoxic agents, brain disorders KANEBO, LTD. (JP) 1995-03-21 US disclosed
EP-0560136-A1 Neuroprotective drug KANEBO, LTD. (JP) 1993-09-15 EP disclosed